Singapore’s healthcare sector is prospected to enjoy multi-year growth due to drivers that lead to increased healthcare spending levels–– including accelerated ageing rates, the rise of lifestyle diseases such as diabetes and hypertension, along with growing disposable incomes.
The listed healthcare sector in Singapore is tracked by the benchmark iEdge SG All Healthcare Index. This index comprises of companies that operate across segments of pharmaceuticals and biotechnology, healthcare and patient services, as well as medical equipment and supplies. There are also 2 healthcare REITs that run patient care facilities such as hospitals and nursing homes in Southeast and Northeast Asia.
With such a robust industry outlook, investors can participate in this growing healthcare sector through SGX-listed health care stocks that are growing across regional and global markets to meet growing patient demand. Here are 4 healthcare services stocks that were the best players of 2019 that you can take a look into.
ISEC Healthcare (SGX: 40T)
Established in 1899, and publicly-listed since 2014, ISEC Healthcare is a medical eye care service provider with ambulatory surgical centres in Malaysia and Singapore. ISEC Healthcare was a top player in the healthcare services sector in 2019, achieving a growth of 48.6%.
The doctors under this group specialise in cataract and refractive surgery (including LASIK), vitreoretinal diseases, corneal and external eye diseases, glaucoma, facial cosmetics, aesthetics surgery and more.
The company is also heavily involved in research and the conducting of clinical trials for pharmaceutical companies. They have presented extensively at both regional and international eye care conferences, and many of the specialist doctors are renowned key opinion leaders in their respective subspecialty fields.
ISEC Healthcare’s share price this week was $0.36 cents, giving it a total market capitalisation of $191.78 million.
ParkwayLife REIT (SGX: C2PU)
ParwayLife REIT was established in 2017 by Parkway Holdings Limited to primarily invest in income-producing real estate and/or real estate-related assets for healthcare-related purposes in the Asia-Pacific Region. They achieved a growth of 31.9% in the healthcare services sector, making them the second-best performer for 2019.
The manager of Parkway Life REIT, PHR Management Pte Ltd was incorporated in Singapore on 19 April 2007, before changing its name to Parkway Trust Management Pte Ltd, and subsequently Parkway Trust Management Limited on 12 July 2007. Parkway Life REIT invests and owns the following properties in Singapore: The Mount Elizabeth Hospital Property, The Gleneagles Hospital Property, and The East Shore Hospital Property.
ParkwayLife REIT’s share price this week was $3.480, with a total market capitalisation of $2,105.41 million.
Read Also: Here Are 5 Common Misconceptions Singaporeans Have About Private Hospitals
Cordlife (SGX: P8A)
Cordlife was incorporated on 2 May 2001 as a private company limited. It achieved a growth of 32.6% in 2019. Public since 2012, Cordlife Group Limited currently comprises of its company and subsidiaries including–– CLS Services, Cordlife Hong Kong, and Cordlife Shanghai.
The Group is among the first private cord blood banks in Asia. Its business is focused on providing cord blood banking services including the collection, processing, testing, cryopreservation and storage of umbilical cord blood at birth. Cordlife Group Limited currently provides cord blood banking serves in Singapore and Hong Kong, including customers from Indonesia, Macau and the Philippines.
Cordlife’s share price closed at $0.445 on 24 January 2020, giving it a total market capitalisation of $119.05 million.
Read Also: MOH Fee Benchmarks For Private Surgical Procedures In Singapore: Here Are 4 Things You Need To Know
First REIT (SGX: AW9U)
First REIT achieved a growth of 9.9% in 2019. First REIT, incorporated and public since 2006, was established with the principal investment objective of owning and investing in a diversified portfolio of income-producing real estate and/or estate-related assets in Asia primarily used for healthcare. These include and are not limited to regional healthcare-related markets with high growth potential such as Indonesia, Singapore, China, Malaysia, Thailand and Hong Kong.
First REIT invests in healthcare and healthcare-related assets positioned to capitalise on the growing demand for healthcare services in Asia. Their initial asset portfolio as at listing date consists fo the following properties, all located in Indonesia: Siloam Hospitals Lippo Karawaci, Siloam Hospitals West Jakarta, Siloam Hospitals Surabaya, and Imperial Aryaduta Hotel and Country Club.
First REIT’s share price closed at $1.000, with a total market capitalisation of $797.67 million.
Read Also: Your Complete Guide To Healthcare Financing In Singapore
4 Stocks This Week is not a recommendation from us to buy or sell any of these stocks. For investors who are keen to find out more, you should continue researching about them before making your investment decisions.
Advertiser Message
Dive Into The Latest Market Updates And Research Reports
With over 25,000 subscribers, SGX Invest Telegram channel has expanded since 2020 to bring you more than just market insights, updates on sector and stock performances, plus all the happenings in Singapore's securities market, tailored for individual investors like you.
